Local Institution

Shimonoseki-shi, Yamaguchi 7500061

0 studies enrolling now · 2 studies all time

What they study most

Hepato Cellular Carcinoma (HCC), Liver Cancer

Studies at this site

• Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment — Completed
• First Line Hepato Cellular Carcinoma (HCC) — Completed